| Date Filed | Type | Description |
| 10/05/2023 |
4
| Wu Yue Alexander (Director) has filed a Form 4 on Scilex Holding Co|
Txns:
| Granted 250,000 options to buy
@ $1.41, valued at
$352.5k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Wu Yue Alexander (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 68,800 options to buy
@ $2.63, valued at
$180.9k
|
|
| 06/15/2020 |
4
| Wu Yue Alexander (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 100,000 options
@ $4.89, valued at
$489k
|
|
| 06/21/2019 |
4
| Wu Yue Alexander (Director) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Granted 57,885 options to buy
@ $3.13, valued at
$181.2k
|
|
| 04/23/2019 |
4
| Wu Yue Alexander (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 70,000 options
@ $3.78, valued at
$264.6k
|
|
| 11/27/2018 |
4
| Wu Yue Alexander (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 35,000 options
@ $3.57, valued at
$125k
|
|
| 09/18/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 09/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2016 |
3
| Wu Yue Alexander (Director) has filed a Form 3 on Sorrento Therapeutics, Inc. |